BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 869341)

  • 1. [Toxic hepatitis caused by rifampin and isoniazid in treatment of tuberculosis (author's transl)].
    Abeledo Mezquita G; Otero Reigada MC
    An Esp Pediatr; 1977 Feb; 10(2):167-70. PubMed ID: 869341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatotoxicity of rifampicin and isoniazid in the treatment of tuberculous meningitis (author's transl)].
    Frontera Izquierdo P; Unceta Aguirre L; Tomás Vila M; Calvo Rigual F; Pérez Tamarit D
    An Esp Pediatr; 1981 Dec; 15(6):549-52. PubMed ID: 7337308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment.
    van Hest R; Baars H; Kik S; van Gerven P; Trompenaars MC; Kalisvaart N; Keizer S; Borgdorff M; Mensen M; Cobelens F
    Clin Infect Dis; 2004 Aug; 39(4):488-96. PubMed ID: 15356811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of acute hepatitis occurred during treatment with isoniazid and rifampicin (author's transl)].
    Kameda K; Kawabata S; Shirai S
    Kekkaku; 1980 May; 55(5):247-51. PubMed ID: 7412075
    [No Abstract]   [Full Text] [Related]  

  • 5. [Detection of the effects of the rifampin-isoniazid combination on the human liver].
    Plomteux G; Heusghem C; Ferdinande R; Lecoq A; Winandy A; Parmentier JC
    Nouv Presse Med; 1974 Mar; 3(12):727-32. PubMed ID: 4836506
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons?
    Gordin FM; Cohn DL; Matts JP; Chaisson RE; O'Brien RJ; ; ;
    Clin Infect Dis; 2004 Aug; 39(4):561-5. PubMed ID: 15356822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of a isoniozid-rifompicin drug hepatotoxicity screening technic in tuberculosis therapy].
    Viteau JM; Toulet J; Plonteux G; Abiven M; Bonfante N
    Sem Hop; 1974 Jun; 50(28):1953-9. PubMed ID: 4374748
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)].
    Kuntz HD; Rausch V
    Prax Klin Pneumol; 1977 Nov; 31(11):925-32. PubMed ID: 928291
    [No Abstract]   [Full Text] [Related]  

  • 9. Short course chemotherapy for tuberculosis in children.
    Padmini R; Srinivasan S; Nalini P; Mahadevan S
    J Trop Pediatr; 1993 Dec; 39(6):361-4. PubMed ID: 8133559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liver tolerance of antitubercular treatment including rifampicin. Study on 214 cases].
    Decroix G; Pujet JC
    Sem Hop; 1973 Jun; 49(30):2219-24. PubMed ID: 4354303
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatotoxicity of the combination of isoniazid-rifampicin in African children. Role of malnutrition and HB virus].
    Gendrel D; Nardou M; Mouba JF; Gahouma D; Moussavou A; Boguikouma JB
    Arch Fr Pediatr; 1989 Nov; 46(9):645-8. PubMed ID: 2604523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic hepatitis with isoniazid and rifampin. A meta-analysis.
    Steele MA; Burk RF; DesPrez RM
    Chest; 1991 Feb; 99(2):465-71. PubMed ID: 1824929
    [No Abstract]   [Full Text] [Related]  

  • 13. [Jaundice and rifampicin. Critical study].
    Nebout T; Dhumeaux D; Berthelot P
    Nouv Presse Med; 1974 Mar; 3(12):733-6. PubMed ID: 4836507
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug-induced hepatitis during a treatment associating isoniazid and rifampicin].
    Jean R; Bonnet H; Pages P; Dumas R; Greze J
    Ann Pediatr (Paris); 1972 Apr; 19(4):307-11. PubMed ID: 5075678
    [No Abstract]   [Full Text] [Related]  

  • 15. Isoniazid-rifampin-induced hepatitis in hepatitis B carriers.
    Wu JC; Lee SD; Yeh PF; Chan CY; Wang YJ; Huang YS; Tsai YT; Lee PY; Ting LP; Lo KJ
    Gastroenterology; 1990 Feb; 98(2):502-4. PubMed ID: 2295408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitubercular drug-induced liver injuries].
    Guo Y; Cui D
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):308-9. PubMed ID: 11326960
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatotoxic reactions in children with severe tuberculosis treated with isoniazid-rifampin.
    Tsagaropoulou-Stinga H; Mataki-Emmanouilidou T; Karida-Kavalioti S; Manios S
    Pediatr Infect Dis; 1985; 4(3):270-3. PubMed ID: 4000989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reversible acute hepatic failure after treatment with association of isoniazide-rifampicin (author's transl)].
    Le Guillou M; L'Henaff F; Boisseau M; Castaing Y; Bourdalle-Badie C
    Sem Hop; 1981 Jun 18-25; 57(25-28):1199-201. PubMed ID: 6266037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis and antitubercular therapy.
    Mahashur AA; Prabhudesai PP
    J Assoc Physicians India; 1991 Aug; 39(8):595-6. PubMed ID: 1814871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.